Kaposiform Hemangioendothelioma (KHE)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Kaposiform Hemangioendothelioma (KHE) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT03001180

Identification of Biomarkers for Patients with Vascular Anomalies

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest pro…

United States1,000 participantsStarted 2015-04

All recent trials (3 shown)

TerminatedPhase 2

NCT02110069

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

In this research study we want to learn more about which treatment works better for patients diagnosed with a vascular tumor called Kaposiform Hemangioendotheli…

United States4 participantsStarted 2017-06-14

Treatment: Vincristine, Sirolimus

UnknownPhase 1

NCT04409691

SCMC Trial on KHE With KMP (V.2020)

a phase I trial focusing on safety and efficacy of prednison shock plus sirolimus maintenance in treating Kaposiform hemangioendothelioma (KHE) with Kasabach-Me…

China20 participantsStarted 2020-07-01

Treatment: prednison and Sirolimus, prednison